Related Experiment Video
Updated: Jun 25, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Melanoma progression, gene expression and DNA microarrays
1Department of Dermatology, University of Zurich, Zurich, Switzerland. keith.hoek@usz.ch
Summary
DNA microarray analysis reveals limited understanding of melanoma progression. Gene expression signatures in cell cultures failed to identify consistent stage-specific patterns, suggesting complexity in melanoma molecular changes.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Melanoma progression is studied using DNA microarray analysis to understand gene expression changes.
- Tissue biopsies from distinct clinical stages are typically assessed.
- Limited insights into melanoma progression have been gained despite these analyses.
Purpose of the Study:
- To compare DNA microarray analyses of tissue biopsies versus cell cultures in melanoma.
- To discuss current understanding of melanoma progression at the molecular level.
- To explore the complexities of stage-specific gene expression in melanoma.
Main Methods:
- Review of DNA microarray studies on melanoma gene expression.
- Comparison of findings from tissue biopsy and cell culture experiments.
- Analysis of molecular changes during melanoma disease progression.
Main Results:
- A significant gene expression shift occurs during the transition from thin to thick primary melanoma lesions.
- Cell culture experiments failed to identify consistent stage-specific gene expression signatures.
- Current approaches have yielded limited understanding of melanoma progression.
Conclusions:
- Melanoma progression is more complex than initially anticipated.
- Stage-specific gene expression signatures in melanoma are challenging to identify.
- Further research is needed to elucidate the molecular mechanisms of melanoma progression.
Related Concept Videos
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
DNA Microarrays
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...

